We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.
Siemens Healthineers has received a strong investment-grade credit rating from Moody’s Ratings, marking an important step in the company’s preparations for being financially independent from its majority shareholder, Siemens AG.
At RSNA 2025, Siemens Healthineers announces Syngo.CT Coronary Cockpit, a new software solution within the Syngo.via platform designed to support the management of coronary artery disease (CAD) for both Dual Source and photon-counting CT scanners.
Here you will find all ad hoc announcements (disclosure of inside information according to Article 17 of Regulation (EU) No 596/2014 on market abuse) and announcements of material transactions with related parties in accordance with section 111c of the German Stock Corporation Act of Siemens Healthineers AG.
